From: High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma
Characteristics | N (%) | CXCR4 | P | CXCR7 | P | SDF-1 | P | |||
---|---|---|---|---|---|---|---|---|---|---|
Low | High | Low | High | Low | High | |||||
Gender | ||||||||||
Male | 60 (61.9) | 22 | 38 | 17 | 43 | 41 | 19 | |||
Female | 37 (38.1) | 15 | 22 | 0.703 | 8 | 29 | 0.463 | 29 | 8 | 0.284 |
Age (years) | ||||||||||
≤60 | 62 (63.9) | 23 | 39 | 18 | 44 | 44 | 18 | |||
>60 | 35 (36.1) | 14 | 21 | 0.777 | 7 | 28 | 0.329 | 26 | 9 | 0.726 |
Tumor size (cm) | ||||||||||
≤4 | 20 ( 20.6 ) | 7 | 13 | 7 | 13 | 12 | 8 | |||
4-7 | 50 (51.5) | 20 | 30 | 14 | 36 | 37 | 13 | |||
>7 | 27(27.9) | 10 | 17 | 0.918 | 4 | 23 | 0.257 | 21 | 6 | 0.371 |
Symptoms at diagnosis | ||||||||||
Incidental | 56 (57.7) | 17 | 39 | 15 | 41 | 43 | 13 | |||
Symptoms | 41 (42.3) | 20 | 21 | 0.065 | 10 | 31 | 0.79 | 27 | 14 | 0.235 |
AJCC stage | ||||||||||
T1 | 66 (68.0) | 25 | 41 | 18 | 48 | 44 | 22 | |||
T2 | 18 (18.6) | 5 | 13 | 5 | 13 | 15 | 3 | |||
T3 and T4 | 13 (13.4) | 7 | 6 | 0.369 | 2 | 11 | 0.774 | 11 | 2 | 0.289 |
Lymph nodal status | ||||||||||
N0 | 20 (20.6) | 11 | 9 | 6 | 14 | 15 | 5 | |||
N1 | 5 (5.2) | 1 | 4 | 1 | 4 | 2 | 3 | |||
NX | 72 (74.2) | 25 | 47 | 0.22 | 19 | 53 | 0.914 | 53 | 19 | 0.264 |
Metastasis | ||||||||||
M0 | 91 (93.8) | 35 | 56 | 22 | 69 | 66 | 25 | |||
M1 | 6 (6.2) | 2 | 4 | 1 | 3 | 3 | 0.176 | 4 | 2 | 0.669 |
Histologic variant | ||||||||||
Clear cell | 81 (83.5) | 33 | 48 | 21 | 60 | 60 | 21 | |||
Others | 16 (16.5) | 4 | 12 | 0.236 | 4 | 12 | 1 | 10 | 6 | 0.369 |
Fuhrman’s grade | ||||||||||
1 | 17 (17.5) | 8 | 9 | 7 | 10 | 7 | 10 | |||
2 | 50 (51.5) | 19 | 31 | 13 | 37 | 41 | 9 | |||
3 | 24 (24.7) | 9 | 15 | 5 | 19 | 18 | 6 | |||
4 | 6 (6.3) | 1 | 5 | 0.676 | 0 | 6 | 0.235 | 4 | 2 | 0.015 |